🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Gloria Iacoboni

Hebron University

ORCID: 0000-0003-0805-9288

Also affiliated with Universitat Autònoma de Barcelona, Vall d'Hebron Institut de Recerca, Vall d'Hebron Hospital Universitari, Vall d'Hebron Institute of Oncology

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 5 papers. Top paper: “Anakinra for Refractory Cytokine Release Syndrome or Immune Effector Cell-Associated Neurotoxicity Syndrome after Chimeric Antigen Receptor T Cell Therapy”.

Anakinra for Refractory Cytokine Release Syndrome or Immune Effector Cell-Associated Neurotoxicity Syndrome after Chimeric Antigen Receptor T Cell Therapy

Transplantation and Cellular Therapy(2023)10.1016/j.jtct.2023.04.001
N/A
3.7DataRank · unranked
144 citations

Emily C. Liang, Qian Wu, Jenna Voutsinas, Pere Barba, Gloria Iacoboni +19 more

Chimeric antigen receptor T‐cell therapy outcomes in T cell/histiocyte‐rich large B‐cell lymphoma and subsequent treatment strategies after disease progression: A GELTAMO/GETH study

HemaSphere(2025)10.1002/hem3.70077
N/A
0.241DataRank · unranked
4 citations

Gloria Iacoboni, Vı́ctor Navarro, Ana C. Caballero, Nuria Martínez, Javier Delgado +10 more

The CAR‐HEMATOTOX score identifies patients at high risk for hematological toxicity, infectious complications, and poor treatment outcomes following brexucabtagene autoleucel for relapsed or refractory MCL

American Journal of Hematology(2023)10.1002/ajh.27056
N/A
0DataRank · unranked
48 citations

Yucai Wang, Omar Albanyan, Javier Muñoz, Pierre Sesques, Gloria Iacoboni +15 more

Non-relapse mortality with bispecific antibodies: A systematic review and meta-analysis in lymphoma and multiple myeloma

Molecular Therapy(2025)10.1016/j.ymthe.2025.03.048
N/A
0DataRank · unranked
13 citations

Mohammad Alhomoud, Roni Shouval, Gloria Iacoboni, Edward R. Scheffer Cliff, Doris K. Hansen +6 more

Optimization and validation of the international metabolic prognostic index for CD19 CAR-T in large B-cell lymphoma

Blood Cancer Journal(2025)10.1038/s41408-025-01338-1
N/A
0DataRank · unranked
8 citations

Sandeep Raj, Michael D. Jain, Gloria Iacoboni, Fabian Müller, Leo Hansmann +26 more